Medical disclaimer: Peptide Clinic Finder is an informational directory and does not diagnose, prescribe, or recommend treatments. Always consult a qualified clinician for medical decisions.

Ipamorelin vs Sermorelin

Both appear in hormone optimisation and longevity clinic listings as GH secretagogue options. Compare provider transparency and monitoring protocols.

Ipamorelin and sermorelin are commonly referenced in clinic protocols aimed at hormone optimisation. Use this comparison to assess how providers explain rationale, eligibility, and monitoring.

Ipamorelin

A GH secretagogue referenced in longevity and performance listings, typically injectable.

Potential benefits

  • Often listed in GH-support protocols.
  • Common in longevity clinic menus.

Considerations

  • Human evidence remains limited.
  • Monitoring practices differ across clinics.
Best for: Comparing clinics that list GH secretagogue protocols.

Sermorelin

A growth hormone–releasing hormone analogue used in hormone optimisation contexts.

Potential benefits

  • Common in longevity and hormone optimisation listings.
  • Often paired with other secretagogues.

Considerations

  • Evidence base varies by provider.
  • Requires clinical assessment.
Best for: Evaluating clinics with structured hormone programmes.
CategoryIpamorelinSermorelin
Directory contextRecovery / performance-focused listing context.Weight / metabolic or longevity listing context.
Common goalsRecovery support, injury pathways, performance.Weight management, metabolic health, longevity programs.
Guidance noteInformational listing only; suitability requires clinician review.Informational listing only; suitability requires clinician review.

Related clinics

Conclusion

These are usually offered by similar clinics. Choose based on provider quality and monitoring standards rather than the peptide label.

Related peptide pages

London treatment pages